Summary

This article discusses pharmacologic dilemmas in the treatment of addiction, including the treatment of insomnia among patients with substance use disorders, the pharmacologic treatment of attention-deficit/hyperactivity disorder (ADHD) among patients with substance use disorders, alcohol pharmacotherapy, as well as opioid agonist and antagonist therapies.